NCT03663946View on ClinicalTrials.gov

A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

May 30, 2020

Study Completion Date

May 30, 2020

Conditions
Renal Cell CarcinomaKidney Cancer
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

170-8630

Local Institution, Tokyo

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY